*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Cilostazol</strong> is a selective phosphodiesterase III inhibitor used primarily in cardiovascular therapy. Its core synthesis involves complex organic coupling reactions. Molecular formula: C<sub>18</sub>H<sub>21</sub>N<sub>5</sub>O<sub>2</sub>; CAS No.: 73963-72-1.</p>
<h3>Application</h3>
<ul>
<li>Treatment of intermittent claudication in peripheral arterial disease.</li>
<li>Improvement of blood flow and reduction of leg pain symptoms.</li>
<li>Prevention of thrombotic events in high-risk patients.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in heart failure; avoid use with strong CYP3A4 inhibitors. Store in cool, dry conditions below 25°C away from direct light to maintain stability.</p>